Fermalogic is a basic research company that explores metabolism using actinomycetes as our model living system. Applications for our research have been developed for pharmaceutical manufacturing as well as new therapeutics and nutraceutical development. Fermalogicâs core expertise is in the handling and manipulation of actinomycetes, which are used in industrial fermentations for the biosynthetic production of antibiotics, anticancer agents, immunosuppressants, and other natural products. Fermalogic also has pioneered the area of co-product recovery from industrial fermentations. Fermalogicâs first technology in co-product development applies to the recovery of isoflavones (genistein and daidzein), from soy-bean based fermentations particularly the erythromycin fermentation Fermalogic is independently owned and operated. Our offices were recently moved into new space that combines offices with a micro/molecular biology lab, still within the Franklin Square complex in Chicagoâs River North area, after having moved out of the Chicago Technology Park in May of 2011. In addition Fermalogic has provided consulting and contract research to the pharmaceutical and agricultural industries including Novartis (Sandoz), Dow Agrosciences, Roussel-Uclaf, and Polfa Tarch
